124 related articles for article (PubMed ID: 37694353)
1. Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing.
Singh V; Katiyar A; Malik P; Kumar S; Mohan A; Singh H; Jain D
Cancer Biomark; 2023 Sep; ():. PubMed ID: 37694353
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing to identify novel somatic mutations in squamous cell lung cancers.
Zheng CX; Gu ZH; Han B; Zhang RX; Pan CM; Xiang Y; Rong XJ; Chen X; Li QY; Wan HY
Int J Oncol; 2013 Sep; 43(3):755-64. PubMed ID: 23799614
[TBL] [Abstract][Full Text] [Related]
3. Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.
Kumar S U; Balasundaram A; Cathryn R H; Varghese RP; R S; R G; Younes S; Zayed H; Doss C GP
Comput Biol Med; 2022 Sep; 148():105701. PubMed ID: 35753820
[TBL] [Abstract][Full Text] [Related]
4. Familial Esophageal Squamous Cell Carcinoma with damaging rare/germline mutations in KCNJ12/KCNJ18 and GPRIN2 genes.
Khalilipour N; Baranova A; Jebelli A; Heravi-Moussavi A; Bruskin S; Abbaszadegan MR
Cancer Genet; 2018 Feb; 221():46-52. PubMed ID: 29405996
[TBL] [Abstract][Full Text] [Related]
5. Multiplatform-based molecular subtypes of non-small-cell lung cancer.
Chen F; Zhang Y; Parra E; Rodriguez J; Behrens C; Akbani R; Lu Y; Kurie JM; Gibbons DL; Mills GB; Wistuba II; Creighton CJ
Oncogene; 2017 Mar; 36(10):1384-1393. PubMed ID: 27775076
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutation variant analysis in rural, resectable non-small cell lung carcinoma patients.
Mitchem JB; Miller A; Manjunath Y; Barbirou M; Raju M; Shen Y; Li G; Avella DM; Chaudhuri AA; Shyu CR; Warren WC; Tonellato PJ; Kaifi JT
Cancer Genet; 2022 Nov; 268-269():75-82. PubMed ID: 36191390
[TBL] [Abstract][Full Text] [Related]
8. Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
Bonfiglio S; Vanni I; Rossella V; Truini A; Lazarevic D; Dal Bello MG; Alama A; Mora M; Rijavec E; Genova C; Cittaro D; Grossi F; Coco S
BMC Cancer; 2016 Aug; 16(1):692. PubMed ID: 27578032
[TBL] [Abstract][Full Text] [Related]
9. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
[TBL] [Abstract][Full Text] [Related]
10. Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing.
O'Rawe J; Jiang T; Sun G; Wu Y; Wang W; Hu J; Bodily P; Tian L; Hakonarson H; Johnson WE; Wei Z; Wang K; Lyon GJ
Genome Med; 2013; 5(3):28. PubMed ID: 23537139
[TBL] [Abstract][Full Text] [Related]
11. Analytical validation of whole exome and whole genome sequencing for clinical applications.
Linderman MD; Brandt T; Edelmann L; Jabado O; Kasai Y; Kornreich R; Mahajan M; Shah H; Kasarskis A; Schadt EE
BMC Med Genomics; 2014 Apr; 7():20. PubMed ID: 24758382
[TBL] [Abstract][Full Text] [Related]
12. Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study.
Liu H; Li F; Zhu Y; Li T; Huang H; Lin T; Hu Y; Qi X; Yu J; Li G
Oncotarget; 2016 Jul; 7(28):43894-43906. PubMed ID: 27270314
[TBL] [Abstract][Full Text] [Related]
13. Whole exome sequencing in recurrent early pregnancy loss.
Qiao Y; Wen J; Tang F; Martell S; Shomer N; Leung PC; Stephenson MD; Rajcan-Separovic E
Mol Hum Reprod; 2016 May; 22(5):364-72. PubMed ID: 26826164
[TBL] [Abstract][Full Text] [Related]
14. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
Front Immunol; 2022; 13():906328. PubMed ID: 35874679
[TBL] [Abstract][Full Text] [Related]
15. Performance assessment of variant calling pipelines using human whole exome sequencing and simulated data.
Kumaran M; Subramanian U; Devarajan B
BMC Bioinformatics; 2019 Jun; 20(1):342. PubMed ID: 31208315
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genomic features of non-small cell lung cancer occurring in families.
Miyabe S; Ito S; Sato I; Abe J; Tamai K; Mochizuki M; Fujimori H; Yamaguchi K; Shindo N; Shima H; Yamazaki T; Abue M; Okada Y; Yasuda J
Thorac Cancer; 2023 Apr; 14(10):940-952. PubMed ID: 36869602
[TBL] [Abstract][Full Text] [Related]
17. Comparison and evaluation of two exome capture kits and sequencing platforms for variant calling.
Zhang G; Wang J; Yang J; Li W; Deng Y; Li J; Huang J; Hu S; Zhang B
BMC Genomics; 2015 Aug; 16(1):581. PubMed ID: 26242175
[TBL] [Abstract][Full Text] [Related]
18. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
[TBL] [Abstract][Full Text] [Related]
19. Whole exome sequencing reveals novel risk genes of pituitary neuroendocrine tumors.
Peculis R; Rovite V; Megnis K; Balcere I; Breiksa A; Nazarovs J; Stukens J; Konrade I; Sokolovska J; Pirags V; Klovins J
PLoS One; 2022; 17(8):e0265306. PubMed ID: 36026497
[TBL] [Abstract][Full Text] [Related]
20. Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer.
Claerhout S; Lehnert S; Vander Borght S; Spans L; Dooms C; Wauters E; Vansteenkiste J; Weynand B; Deraedt K; Bourgain C; Vanden Bempt I
Lung Cancer; 2022 Apr; 166():242-249. PubMed ID: 35378489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
